BothamP.A., LesleyK.E., FentemJ.H., RoguetR., & van de SandtJ.J.M. (1998). Alternative methods for skin irritation testing: the current status. ECVAM Skin Irritation Task Force Report 1. ATLA26, 195–211.
2.
FallerC., BracherM., DamiN., & RoguetR. (2002). Predictive ability of reconstructed human epidermis equivalents for assessment of skin irritation of cosmetics. Toxicology in Vitro16, 557–572.
3.
FentemJ.H., BriggsD., ChesneC., ElliottG.R., HarbellJ.W., HeylingsJ.R., PortesP., van de SandtJ.J.M., & BothamP.A. (2001). A prevalidation study on in vitro tests for acute skin irritation: results and evaluation by the Management Team. Toxicology in Vitro15, 57–93.
4.
ZuangV., BallsM., BothamP.A., CoquetteA., CorsiniE., CurrenR.D., ElliottG.R., FentemJ.H., HeylingsJ.R., LiebschM., MedinaJ., RoguetR., van de SandtJ.J.M., WiemannC., & WorthA.P. (2002). Follow-up to the ECVAM prevalidation study on the in vitro tests for acute skin irritation. ECVAM Skin Irritation Task Force Report 2. ATLA30, 109–129.
5.
HeylingsJ.R., DiotS., EsdaileD.J., FasanoW.J., ManningL.A., & OwenH.M. (2003). A prevalidation study on the in vitro irritation function test (SIFT) for prediction of acute skin irritation in vivo: results and evaluation of ECVAM phase III. Toxicology in Vitro17, 123–138.
6.
KandárováH., LiebschM., GenschowE., GernerI., TraueD., SlawikB., & SpielmannH. (2004). Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX21, 107–114.
7.
KandárováH., LiebschM., GernerI., SchmidtE., GenschowE., TraueD., & SpielmannH. (2005). The EpiDerm test protocol for the upcoming ECVAM validation study on the skin irritation tests — An assessment of the performance of the optimised test. ATLA33, 351–367.
8.
CotovióJ., GrandidierM-H., PortesP., RoguetR., & RubinsteenG. (2005). The in vitro acute skin irritation of chemicals: Optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. ATLA33, 329–249.
